New antiepileptic drugs and women

Seizure

Volumn 23, Issue 8, 2014, Pages 585-591

  Reimers, Arne ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Breastfeeding; Contraception; Menopause; New antiepileptic drugs; Pregnancy; Women

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PERAMPANEL; PHENOBARBITAL; PHENYTOIN; PREGABALIN; RETIGABINE; SEX HORMONE; STIRIPENTOL; VIGABATRIN; ZONISAMIDE; CONTRACEPTIVE AGENT;

BONE DENSITY; BREAST FEEDING; DRUG MONITORING; DRUG SAFETY; DRUG TOLERANCE; HOMEOSTASIS; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEIZURE; WOMEN'S HEALTH; BONE; DRUG EFFECTS; FEMALE; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANTICONVULSANTS; BONE AND BONES; BREAST FEEDING; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; PREGNANCY;

EID: 84906314492     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2014.05.004     Document Type: Review

References (125)

1. M. Bialer Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia 53 Suppl. 7 2012 26 33
2. C. Johannessen Landmark Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy CNS Drugs 22 2008 27 47
3. H.M. Hamer, R. Dodel, A. Strzelczyk, M. Balzer-Geldsetzer, J.P. Reese, and O. Schoffski et al. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany - a nationwide population-based study in children and adults J Neurol 259 2012 2376 2384
4. L.P. Hsieh, and C.Y. Huang Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study Epilepsy Res 96 2011 81 88
5. C.J. Landmark, H. Fossmark, P.G. Larsson, E. Rytter, and S.I. Johannessen Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population Epilepsy Res 95 2011 51 59
6. J.M. Nicholas, L. Ridsdale, M.P. Richardson, M. Ashworth, and M.C. Gulliford Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database Seizure 21 2012 466 470
7. W.O. Pickrell, A.S. Lacey, R.H. Thomas, R.A. Lyons, P.E. Smith, and M.I. Rees Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010 Seizure 23 2014 77 80
8. O. van Hecke, N. Torrance, and B.H. Smith Chronic pain epidemiology and its clinical relevance Br J Anaesth 111 2013 13 18
9. R.C. Kessler, M. Petukhova, N.A. Sampson, A.M. Zaslavsky, and H.U. Wittchen Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States Int J Methods Psychiatr Res 21 2012 169 184
10. C. Nadebaum, V. Anderson, F. Vajda, D. Reutens, and A. Wood Neurobehavioral consequences of prenatal antiepileptic drug exposure Dev Neuropsychol 37 2012 1 29
11. T. Tomson, and D. Battino Teratogenic effects of antiepileptic drugs Lancet Neurol 11 2012 803 813
12. A. Verrotti, C. D'Egidio, A. Mohn, G. Coppola, P. Parisi, and F. Chiarelli Antiepileptic drugs, sex hormones, and PCOS Epilepsia 52 2011 199 211
13. L. Forsberg, K. Wide, and B. Kallen School performance at age 16 in children exposed to antiepileptic drugs in utero - a population-based study Epilepsia 52 2011 364 369
14. T. Erel, and O. Guralp Epilepsy and menopause Arch Gynecol Obstet 284 2011 749 755
15. C.L. Harden, P.B. Pennell, B.S. Koppel, C.A. Hovinga, B. Gidal, and K.J. Meador et al. Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society Epilepsia 50 2009 1247 1255
16. T. Tomson, C.J. Landmark, and D. Battino Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications Epilepsia 54 2013 405 414
17. L.S. Roste, E. Tauboll, S. Svalheim, and L. Gjerstad Does menopause affect the epilepsy? Seizure 17 2008 172 175
18. E. Burakgazi, C. Harden, and J.J. Kelly Contraception for women with epilepsy Rev Neurol Dis 6 2009 E62 E67
19. D. Molgaard-Nielsen, and A. Hviid Newer-generation antiepileptic drugs and the risk of major birth defects JAMA 305 2011 1996 2002
20. W.V. Bobo, R.L. Davis, S. Toh, D.K. Li, S.E. Andrade, and T.C. Cheetham et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study Paediatr Perinat Epidemiol 26 2012 578 588
21. N.L. Harrison, M.D. Majewska, J.W. Harrington, and J.L. Barker Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex J Pharmacol Exp Ther 241 1987 346 353
22. J. Logothetis, R. Harner, F. Morrell, and F. Torres The role of estrogens in catamenial exacerbation of epilepsy Neurology 9 1959 352 360
23. M.D. Majewska, N.L. Harrison, R.D. Schwartz, J.L. Barker, and S.M. Paul Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor Science 232 1986 1004 1007
24. E.M. Marcus, C.W. Watson, and P.L. Goldman Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit Arch Neurol 15 1966 521 532
25. H.E. Scharfman, and N.J. MacLusky The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female Epilepsia 47 2006 1423 1440
26. E. Lofgren, J.S. Tapanainen, R. Koivunen, A. Pakarinen, and J.I. Isojarvi Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy Epilepsia 47 2006 1441 1446
27. M. Hill, J. Vrbikova, J. Zarubova, R. Kancheva, M. Velikova, and L. Kancheva et al. The steroid metabolome in lamotrigine-treated women with epilepsy Steroids 76 2011 1351 1357
28. S. Svalheim, E. Tauboll, G. Luef, A. Lossius, M. Rauchenzauner, and F. Sandvand et al. Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults Epilepsy Behav 16 2009 281 287
29. M. Rauchenzauner, G. Bitsche, S. Svalheim, E. Tauboll, E. Haberlandt, and L. Wildt et al. Effects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children - results from a pilot study Epilepsy Res 88 2010 264 268
30. E. Tauboll, E.L. Gregoraszczuk, A.K. Wojtowicz, and T. Milewicz Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells Epilepsia 50 2009 1868 1874
31. M.J. Morrell, F.J. Hayes, P.M. Sluss, J.M. Adams, M. Bhatt, and C. Ozkara et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine Ann Neurol 64 2008 200 211
32. L.J. Stephen, G.J. Sills, J.P. Leach, E. Butler, P. Parker, and N. Hitiris et al. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy Epilepsy Res 75 2007 122 129
33. G.L. Hammond Diverse roles for sex hormone-binding globulin in reproduction Biol Reprod 85 2011 431 441
34. J. Sidhu, S. Job, S. Singh, and R. Philipson The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects Br J Clin Pharmacol 61 2006 191 199
35. H. Chen, K. Yang, S. Choi, J.H. Fischer, and H. Jeong Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy Drug Metab Dispos 37 2009 1841 1847
36. A.G. Herzog, A.S. Blum, E.L. Farina, X.E. Maestri, J. Newman, and E. Garcia et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use Neurology 72 2009 911 914
37. A. Reimers, E. Brodtkorb, G. Helde, and O. Spigset Lamotrigine serum concentrations throughout the menstrual cycle - a study of 2 cases Clin Neuropharmacol 29 2006 160 162
38. I. Wegner, P.M. Edelbroek, S. Bulk, and D. Lindhout Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives Neurology 73 2009 1388 1393
39. J. Brochner-Mortensen, P. Paaby, P. Fjeldborg, K. Raffn, C.E. Larsen, and J. Moller-Petersen Renal haemodynamics and extracellular homeostasis during the menstrual cycle Scand J Clin Lab Invest 47 1987 829 835
40. Fycompa prescribing information U.S. Food and Drug Administration 2014 http://www.accessdata.fda.gov/drugsatfda-docs/label/2012/202834lbl.pdf
41. W. Cawello, B. Rosenkranz, B. Schmid, and W. Wierich Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Epilepsia 54 2013 530 536
42. C.S. Crean, D.J. Tompson, and M. Buraglio The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent Int J Clin Pharmacol Ther 51 2013 847 853
43. M.A. Eldon, B.A. Underwood, E.J. Randinitis, and A.J. Sedman Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol Neurology 50 1998 1146 1148
44. S.G. Griffith, and Y. Dai Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women Clin Ther 26 2004 2056 2065
45. I. Ragueneau-Majlessi, R.H. Levy, and F. Janik Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women Epilepsia 43 2002 697 702
46. G. Sills, and M. Brodie Pharmacokinetics and drug interactions with zonisamide Epilepsia 48 2007 435 441
47. GlaxoSmithKline Lamictal summary of product characteristics (SPC) 2014 http://www.medicines.org.uk/emc/medicine/4228/SPC last updated 08/04/2014 [accessed 08.05.14]
48. Eisai Fycompa summary of product characteristics (SPC) 2013 http://www.medicines.org.uk/emc/medicine/26951/SPC/ Fycompa+2mg%2c4mg%2c6mg%2c8mg%2c10mg%2c12mg+film-coated+tablets last updated 28/11/2013 [accessed 08.05.13]
49. M. Bialer, and P. Soares-da-Silva Pharmacokinetics and drug interactions of eslicarbazepine acetate Epilepsia 53 2012 935 946
50. C. Fattore, G. Cipolla, G. Gatti, G.L. Limido, Y. Sturm, and C. Bernasconi et al. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women Epilepsia 40 1999 783 787
51. D.R. Doose, S.S. Wang, M. Padmanabhan, S. Schwabe, D. Jacobs, and M. Bialer Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects Epilepsia 44 2003 540 549
52. W.E. Rosenfeld, D.R. Doose, S.A. Walker, and R.K. Nayak Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy Epilepsia 38 1997 317 323
53. A. Sabers, J.M. Buchholt, P. Uldall, and E.L. Hansen Lamotrigine plasma levels reduced by oral contraceptives Epilepsy Res 47 2001 151 154
54. A. Reimers, G. Helde, and E. Brodtkorb Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations Epilepsia 46 2005 1414 1417
55. A. Sabers, and J. Christensen No effect of oral contraceptives on the metabolism of levetiracetam Epilepsy Res 95 2011 277 279
56. G.D. Anderson, and D.B. Carr Effect of pregnancy on the pharmacokinetics of antihypertensive drugs Clin Pharmacokinet 48 2009 159 168
57. S.N. Sturgiss, W. Dunlop, and J.M. Davison Renal haemodynamics and tubular function in human pregnancy Baillieres Clin Obstet Gynaecol 8 1994 209 234
58. N. Isoherranen, and K.E. Thummel Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos 41 2013 256 262
59. T.L. Reisinger, M. Newman, D.W. Loring, P.B. Pennell, and K.J. Meador Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy Epilepsy Behav 29 2013 13 18
60. C. Johannessen Landmark, S.I. Johannessen, and T. Tomson Host factors affecting antiepileptic drug delivery-pharmacokinetic variability Adv Drug Deliv Rev 64 2012 896 910
61. A. Sabers Algorithm for lamotrigine dose adjustment before, during, and after pregnancy Acta Neurol Scand 126 2012 e1 e4
62. I. Ohman, O. Beck, S. Vitols, and T. Tomson Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy Epilepsia 49 2008 1075 1080
63. P.B. Pennell, L. Peng, D.J. Newport, J.C. Ritchie, A. Koganti, and D.K. Holley et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency Neurology 70 2008 2130 2136
64. V. Petrenaite, A. Sabers, and J. Hansen-Schwartz Individual changes in lamotrigine plasma concentrations during pregnancy Epilepsy Res 65 2005 185 188
65. A. Reimers, G. Helde, G. Brathen, and E. Brodtkorb Lamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol Epilepsy Res 94 2011 198 205
66. T. Tomson, I. Ohman, and S. Vitols Lamotrigine in pregnancy and lactation: a case report Epilepsia 38 1997 1039 1041
67. T.A. Tran, I.E. Leppik, K. Blesi, S.T. Sathanandan, and R. Remmel Lamotrigine clearance during pregnancy Neurology 59 2002 251 255
68. G.J. de Haan, P. Edelbroek, J. Segers, M. Engelsman, D. Lindhout, and M. Devile-Notschaele et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study Neurology 63 2004 571 573
69. C. Fotopoulou, R. Kretz, S. Bauer, J.C. Schefold, B. Schmitz, and J.W. Dudenhausen et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period Epilepsy Res 85 2009 60 64
70. C.T. Clark, A.M. Klein, J.M. Perel, J. Helsel, and K.L. Wisner Lamotrigine dosing for pregnant patients with bipolar disorder Am J Psychiatry 170 2013 1240 1247
71. D. Battino, T. Tomson, E. Bonizzoni, J. Craig, D. Lindhout, and A. Sabers et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry Epilepsia 54 2013 1621 1627
72. I. Ohman, G. Luef, and T. Tomson Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites Seizure 17 2008 199 202
73. A.A. Westin, A. Reimers, G. Helde, K.O. Nakken, and E. Brodtkorb Serum concentration/dose ratio of levetiracetam before, during and after pregnancy Seizure 17 2008 192 198
74. T. Tomson, R. Palm, K. Kallen, E. Ben-Menachem, B. Soderfeldt, and B. Danielsson et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation Epilepsia 48 2007 1111 1116
75. A.A. Westin, K.O. Nakken, S.I. Johannessen, A. Reimers, K.M. Lillestolen, and E. Brodtkorb Serum concentration/dose ratio of topiramate during pregnancy Epilepsia 50 2009 480 485
76. I. Ohman, A. Sabers, P. de Flon, G. Luef, and T. Tomson Pharmacokinetics of topiramate during pregnancy Epilepsy Res 87 2009 124 129
77. I. Mazzucchelli, F.Y. Onat, C. Ozkara, D. Atakli, L.M. Specchio, and A.L. Neve et al. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium Epilepsia 47 2006 504 509
78. J. Christensen, A. Sabers, and P. Sidenius Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy Neurology 67 2006 1497 1499
79. V. Petrenaite, A. Sabers, and J. Hansen-Schwartz Seizure deterioration in women treated with oxcarbazepine during pregnancy Epilepsy Res 84 2009 245 249
80. K. Kawada, S. Itoh, T. Kusaka, K. Isobe, and M. Ishii Pharmacokinetics of zonisamide in perinatal period Brain Dev 24 2002 95 97
81. K.S. Oles, and W.L. Bell Zonisamide concentrations during pregnancy Ann Pharmacother 42 2008 1139 1141
82. G. Koren Pharmacokinetics in pregnancy; clinical significance J Popul Ther Clin Pharmacol 18 2011 e523 e527
83. R.L. Hancock, G. Koren, A. Einarson, and W.J. Ungar The effectiveness of Teratology Information Services (TIS) Reprod Toxicol 23 2007 125 132
84. A. Lupattelli, O. Spigset, and H. Nordeng Adherence to medication for chronic disorders during pregnancy: results from a multinational study Int J Clin Pharm 36 2014 145 153
85. D. Matsui Adherence with drug therapy in pregnancy Obstet Gynecol Int 2012 2012 796590
86. H. Nordeng, E. Ystrom, and A. Einarson Perception of risk regarding the use of medications and other exposures during pregnancy Eur J Clin Pharmacol 66 2010 207 214
87. J. Liporace, A. Kao, and A. D'Abreu Concerns regarding lamotrigine and breast-feeding Epilepsy Behav 5 2004 102 105
88. D.J. Newport, P.B. Pennell, M.R. Calamaras, J.C. Ritchie, M. Newman, and B. Knight et al. Lamotrigine in breast milk and nursing infants: determination of exposure Pediatrics 122 2008 e223 e231
89. A. Reimers, E. Skogvoll, J.K. Sund, and O. Spigset Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions Eur J Clin Pharmacol 63 2007 687 692
90. S.J. Miyagi, and A.C. Collier Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4 Drug Metab Dispos 35 2007 1587 1592
91. S. Gentile Lamotrigine in pregnancy and lactation Arch Womens Ment Health 8 2005 57 58
92. I. Ohman, S. Vitols, and T. Tomson Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation Epilepsia 41 2000 709 713
93. M. Page-Sharp, J.H. Kristensen, L.P. Hackett, R.G. Beran, J. Rampono, and T.W. Hale et al. Transfer of lamotrigine into breast milk Ann Pharmacother 40 2006 1470 1471
94. B. Rambeck, G. Kurlemann, S.R. Stodieck, T.W. May, and U. Jurgens Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child Eur J Clin Pharmacol 51 1997 481 484
95. E. Nordmo, L. Aronsen, K. Wasland, L. Smabrekke, and S. Vorren Severe apnea in an infant exposed to lamotrigine in breast milk Ann Pharmacother 43 2009 1893 1897
96. K.J. Meador, G.A. Baker, N. Browning, J. Clayton-Smith, D.T. Combs-Cantrell, and M. Cohen et al. Effects of breastfeeding in children of women taking antiepileptic drugs Neurology 75 2010 1954 1960
97. S.I. Johannessen, G. Helde, and E. Brodtkorb Levetiracetam concentrations in serum and in breast milk at birth and during lactation Epilepsia 46 2005 775 777
98. G. Kramer, I. Hosli, R. Glanzmann, and W. Holzgreve Levetiracetam accumulation in human breast milk Epilepsia 43 2002 105
99. P. Bulau, W.D. Paar, and G.E. von Unruh Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother Eur J Clin Pharmacol 34 1988 311 313
100. B. Pedersen Oxcarbazepine in breast milk 17th international epilepsy congress Jerusalem, Israel 1987
101. S. Eisenschenk Treatment with oxcarbazepine during pregnancy Neurologist 12 2006 249 254
102. S. Gentile Oxcarbazepine in pregnancy and lactation Clin Drug Investig 23 2003 687
103. U.C. Lutz, G. Wiatr, H.J. Gaertner, and M. Bartels Oxcarbazepine treatment during breast-feeding: a case report J Clin Psychopharmacol 27 2007 730 732
104. I. Öhman, and T. Tomson Pharmacokinetics of oxcarbazepine in neonatal period and during lactation Epilepsia 50 2009 239
105. S. Gentile Topiramate in pregnancy and breastfeeding Clin Drug Investig 29 2009 139 141
106. I. Ohman, S. Vitols, G. Luef, B. Soderfeldt, and T. Tomson Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations Epilepsia 43 2002 1157 1160
107. H. Ando, S. Matsubara, A. Oi, R. Usui, M. Suzuki, and A. Fujimura Two nursing mothers treated with zonisamide: should breast-feeding be avoided? J Obstet Gynaecol Res 40 2014 275 278
108. R. Shimoyama, T. Ohkubo, and K. Sugawara Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method Biomed Chromatogr 13 1999 370 372
109. J.H. Kristensen, K.F. Ilett, L.P. Hackett, and R. Kohan Gabapentin and breastfeeding: a case report J Hum Lact 22 2006 426 428
110. I. Ohman, S. Vitols, and T. Tomson Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 46 2005 1621 1624
111. C.L. Harden, A.G. Herzog, B.G. Nikolov, B.S. Koppel, P.J. Christos, and K. Fowler et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study Epilepsia 47 2006 1447 1451
112. C.L. Harden Hormone replacement therapy: will it affect seizure control and AED levels? Seizure 17 2008 176 180
113. T. Tomson, S. Lukic, and I. Ohman Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database Epilepsy Behav 19 2010 86 88
114. I. Wegner, A.J. Wilhelm, J.W. Sander, and D. Lindhout The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study Epilepsy Behav 29 2013 217 221
115. K.E. Ensrud, T.S. Walczak, T. Blackwell, E.R. Ensrud, P.J. Bowman, and K.L. Stone Antiepileptic drug use increases rates of bone loss in older women: a prospective study Neurology 62 2004 2051 2057
116. M.A. Lyngstad-Brechan, E. Tauboll, K.O. Nakken, L. Gjerstad, K. Godang, and R. Jemtland et al. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy Scand J Clin Lab Invest 68 2008 759 766
117. N. Jette, L.M. Lix, C.J. Metge, H.J. Prior, J. McChesney, and W.D. Leslie Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis Arch Neurol 68 2011 107 112
118. R.H. Lee, K.W. Lyles, R. Sloane, and C. Colon-Emeric The association of newer anticonvulsant medications and bone mineral density Endocr Pract 2012 1 22
119. S. Bauer, L.C. Hofbauer, M. Rauner, A. Strzelczyk, C. Kellinghaus, and S. Hallmeyer-Elgner et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED) - a prospective multicenter study Epilepsy Res 106 2013 417 422
120. S.A. Beniczky, J. Viken, L.T. Jensen, and N.B. Andersen Bone mineral density in adult patients treated with various antiepileptic drugs Seizure 21 2012 471 472
121. D.L. Koo, K.J. Hwang, S.W. Han, J.Y. Kim, E.Y. Joo, and W.C. Shin et al. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy Epilepsy Res 108 2014 442 447
122. C. Meier, and M.E. Kraenzlin Antiepileptics and bone health Ther Adv Musculoskelet Dis 3 2011 235 243
123. S. Mintzer, P. Boppana, J. Toguri, A. DeSantis, and D. Vitamin levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine Epilepsia 47 2006 510 515
124. K. Phabphal, A. Geater, K. Limapichat, P. Sathirapanya, S. Setthawatcharawanich, and R. Leelawattana Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy Epilepsia 54 2013 e94 e98
125. L.S. Nissen-Meyer, S. Svalheim, E. Tauboll, S. Reppe, T. Lekva, and L.B. Solberg et al. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism Epilepsia 48 2007 1850 1860